Repository of colleges and higher education institutions

Show document
A+ | A- | Help | SLO | ENG

Title:SPREMLJANJE BOLNIKOV Z DEMENCO OB FARMAKOLOŠKEM ZDRAVLJENJU
Authors:ID Erjavec, Lucija (Author)
ID Jurič, Damijana Mojca (Mentor) More about this mentor... New window
Files:.pdf 2726$$lucija_erjavec_dn-_koncna.pdf (3,48 MB)
MD5: A8087C9DF356C5F949F1A17E686AC0F9
 
Language:Slovenian
Work type:Bachelor thesis/paper
Organization:UNM FZV - University of Novo mesto - Faculty of Health Sciences
Abstract:zhodišča: Demenca je ena najpogostejših nevrodegenerativnih bolezni, ki pomembno vpliva na kognitivne, vedenjske in telesne funkcije bolnikov ter predstavlja velik izziv za zdravstveno oskrbo. Glavni namen raziskave je bil preučiti spremljanje bolnikov z demenco ob farmakološkem zdravljenju, prepoznati izzive, povezane s tem procesom, in ovrednotiti možnosti za izboljšanje prakse. Metode: Izvedena je bila kvalitativna raziskava s pomočjo fokusnih skupin. V raziskavi je sodelovalo deset zdravstvenih delavcev – pet medicinskih sester in pet zdravnikov – zaposlenih na Nevrološki kliniki, Kliničnem oddelku za bolezni živčevja Alfreda Šerka, Univerzitetnega kliničnega centra Ljubljana. Podatki so bili zbrani z delno strukturiranim intervjujem v fokusnih skupinah, nato pa analizirani z uporabo tematske analize, kar je omogočilo identifikacijo ključnih tem in kod v izjavah udeležencev. Rezultati: Med glavnimi izzivi so udeleženci izpostavili pomanjkanje farmakološkega znanja, časovne in kadrovske omejitve ter potrebo po boljši dokumentaciji. Antidementivi, kot so rivastigmin, donepezil, galantemin in memantin, so bili prepoznani kot ključni za zgodnje faze demence, medtem ko so antipsihotiki učinkoviti za obvladovanje vedenjskih simptomov. Sistematična uporaba obrazca BSO-DOS? bi lahko izboljšala spremljanje vedenjskih sprememb in prilagoditev terapij. Razprava: Multidisciplinarno sodelovanje, dodatno izobraževanje in uvedba standardiziranih orodij, kot je obrazec BSO-DOS?, so ključni za izboljšanje oskrbe bolnikov. Priporočljivo je tudi večje vključevanje nefarmakoloških metod, ki dopolnjujejo farmakološko zdravljenje in zmanjšujejo neželene učinke.
Keywords:demenca, antidementivi, farmakološko zdravljenje, spremljanje bolnikov z demenco, multidisciplinarni tim.
Year of publishing:2025
PID:20.500.12556/ReVIS-11646 New window
Publication date in ReVIS:26.04.2025
Views:111
Downloads:2
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:English
Title:MONITORING PATIENTS WITH DEMENTIA OF PHARMACOLOGICAL TREATMENT
Abstract:Introduction: Dementia is one of the most common neurodegenerative diseases, significantly affecting patients' cognitive, behavioral, and physical functions, and posing a major challenge to healthcare systems. The main aim of this research was to examine the monitoring of patients with dementia during pharmacological treatment, identify challenges associated with this process, and evaluate opportunities for improving practices. Methods: A qualitative study was conducted using focus group interviews. The study included ten healthcare professionals—five nurses and five physicians—employed at the Neurology Clinic, Alfred Šerko Department of Neurological Disorders, University Medical Centre Ljubljana. Data were collected through semi-structured interviews in focus groups and subsequently analyzed using thematic analysis, which enabled the identification of key themes and codes in the participants' statements. Results: Participants highlighted major challenges such as a lack of pharmacological knowledge, time constraints, staffing limitations, and the need for better documentation. Antidementia drugs, such as rivastigmine, donepezil, galantamine and memantine, were identified as crucial in the early stages of dementia, while antipsychotics were effective in managing behavioral symptoms. Systematic use of the BSO-DOS form could enhance the monitoring of behavioral changes and improve therapy adjustments. Discussion: Multidisciplinary collaboration, additional training, and the introduction of standardized tools, such as the BSO-DOS form, are essential for improving patient care. Greater integration of non-pharmacological methods, complementing pharmacological treatments and reducing side effects, is also recommended.
Keywords:dementia, antidementia drugs, pharmacological treatment, monitoring patients with dementia, multidisciplinary team.


Back